US Contrast Media Market

The report "US Contrast Media Market by Product (Microbubble, Iodine, Gadolinium, Barium-based), Modality (CT, MRI, Ultrasound, X-ray), Indication (Cancer, GIT, CVD, Musculoskeletal, Neurology), Route of Administration (IV, Oral, Rectal), End User-Forecast to 2031", The US contrast media market is expected to reach USD 4.06 billion by 2031, from USD 2.97 billion in 2026, with a CAGR of 6.5%. As the clinical environment evolves and diagnostic techniques become more complex, the US market for contrast media continues to grow, driven by advances in minimally invasive procedures and image-guided therapy, especially in cardiology and interventional radiology, where real-time visualization provided by contrast agents is crucial. Many innovations are being developed as the healthcare delivery model shifts from inpatient to outpatient settings. The rise of high-throughput imaging centers has also led to increased routine use of contrast material.

Browse 120 market data Tables and 50 Figures spread through 200 Pages and in-depth TOC on "US Contrast Media Market by Product (Microbubble, Iodine, Gadolinium, Barium-based), Modality (CT, MRI, Ultrasound, X-ray), Indication (Cancer, GIT, CVD, Musculoskeletal, Neurology), Route of Administration (IV, Oral, Rectal), End User-Forecast to 2031"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/united-states-contrast-media-market-256191149.html

By type, iodinated contrast media are expected to be the largest segment during the forecast period.

Iodinated contrast agents make up the largest part of the US contrast media market because they are widely used across various diagnostic and interventional imaging procedures. These agents are primarily utilized in CT imaging, angiography, and fluoroscopic exams, which account for a significant portion of patient imaging in emergencies, cardiovascular assessments, trauma evaluations, and cancer diagnostics. Their quick and easy availability, reliable diagnostic results, and compatibility with advanced CT systems ensure this technology will remain trusted and widely used in clinical settings. With ongoing improvements in the safety and effectiveness of iodinated contrast products, as well as their increasing availability in many healthcare facilities and doctors’ offices, iodinated contrast agents are expected to remain a leading choice in the US.

By form, liquid is expected to be the largest segment during the forecast period.

Liquid formulations hold a significant share in the US contrast media market because they provide greater convenience. They can also be prepared quickly and integrated with automated injector systems to enhance imaging facility efficiency. Liquid contrast agents enable more precise dosing that can be administered rapidly during high-volume CT scans, magnetic resonance imaging (MRI), and angiography. Therefore, they are effective in both emergency and routine diagnostic settings. The ability of liquid contrast agents to streamline workflows, reduce preparation time, and minimize handling errors has led to their widespread adoption by hospitals, clinics, and outpatient imaging centers. As a result, liquid contrast agents remain the preferred choice in the US.

Key market players include GE Healthcare (US), Bayer AG (Germany), Bracco Imaging (Italy), and Guerbet (France), among others. These companies employ various organic and inorganic strategies to maintain a strong foothold in the US contrast media market.

Don’t miss out on business opportunities in US Contrast Media Market. Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: [email protected]
Visit Our Website: https://www.marketsandmarkets.com